Realtime | Geld | Brief | Zeit |
---|---|---|---|
12,600 | 13,250 | 21:51 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Di | PIHLAJALINNA OYJ: Invitation to Pihlajalinna's Capital Markets Day on 9 May 2025 | 1 | Cision News | ||
19.03. | PIHLAJALINNA OYJ: Pihlajalinna Plc: Notice to Annual General Meeting | 1 | Cision News | ||
14.03. | PIHLAJALINNA OYJ: Pihlajalinna's disposal of own shares based on the share-based incentive programme | 2 | Cision News | ||
12.02. | Pihlajalinna Oyj: Pihlajalinna Financial Statements Release 1 January-31 December 2024: Strong organic growth, operating cash flow and profitability development in 2024 | 52 | GlobeNewswire (Europe) | Pihlajalinna Plc Financial Statements Release 12 February 2025 at 8:00 a.m.
Pihlajalinna Financial Statements Release 1 January-31 December 2024
Strong organic growth, operating cash flow... ► Artikel lesen | |
28.01. | PIHLAJALINNA OYJ: Pihlajalinna Plc publishes Financial Statements Release 2024 on Wednesday, 12 February 2025 | 1 | Cision News | ||
17.01. | PIHLAJALINNA OYJ: Proposals of Pihlajalinna Plc's Shareholders' Nomination Board to the 2025 Annual General Meeting | 1 | Cision News | ||
PIHLAJALINNA Aktie jetzt für 0€ handeln | |||||
13.12.24 | PIHLAJALINNA OYJ: Pihlajalinna establishes a new long-term share-based incentive plan for key employees | 1 | Cision News | ||
11.11.24 | PIHLAJALINNA OYJ: Pihlajalinna Plc: Managers' transactions | 2 | Cision News | ||
07.11.24 | Pihlajalinna Oyj: Pihlajalinna Interim Report 1 January-30 September 2024: Solid development in organic growth and profitability | 68 | GlobeNewswire (Europe) | Pihlajalinna Plc Interim Report 7 November 2024 at 8:00 a.m.
Pihlajalinna Interim Report 1 January-30 September 2024
Solid development in organic... ► Artikel lesen | |
30.10.24 | Pihlajalinna Oyj: Insider information, positive profit warning: Pihlajalinna upgrades its profitability guidance for 2024 and provides preliminary information on revenue and profitability for the third quarter of 2024 | 97 | GlobeNewswire (Europe) | Pihlajalinna Plc Insider Information 30 October 2024 at 8:00 a.m.
Insider information, positive profit warning: Pihlajalinna upgrades its profitability guidance... ► Artikel lesen | |
28.10.24 | PIHLAJALINNA OYJ: Insider information: The Wellbeing Services County of Pirkanmaa terminates the complete outsourcing agreement of Kolmostien Terveys | 2 | Cision News | ||
25.10.24 | PIHLAJALINNA OYJ: Pihlajalinna Plc publishes Interim Report for January 1-September 30, 2024, on Thursday, 7 November 2024 | 3 | Cision News | ||
23.10.24 | PIHLAJALINNA OYJ: Insider information: The Wellbeing Services County of Pirkanmaa proposes to terminate Pihlajalinna's complete outsourcing agreement in Parkano and Kihniö | 1 | Cision News | ||
09.08.24 | Pihlajalinna Oyj: Pihlajalinna Half Year Financial Report 1 January-30 June 2024: Profitability and customer satisfaction continued to improve | 122 | GlobeNewswire (Europe) | Pihlajalinna Plc Half Year Financial Report 9 August 2024 at 8:00 a.m.
Pihlajalinna Half Year Financial Report 1 January-30 June 2024
Profitability and customer... ► Artikel lesen | |
17.07.24 | Pihlajalinna Oyj: Insider information, profit warning: Pihlajalinna raises its profitability guidance for 2024 and provides preliminary information on revenue and profitability for the second quarter of 2024 | 106 | GlobeNewswire (Europe) | Pihlajalinna Plc Insider Information 17 July 2024 at 8:00 a.m.
Insider information, profit warning: Pihlajalinna raises its profitability guidance for 2024 and provides preliminary... ► Artikel lesen | |
03.05.24 | Pihlajalinna Oyj: Pihlajalinna Interim Report 1 January-31 March 2024: Profitability continued to improve, operating cash flow was strong | 118 | GlobeNewswire (Europe) | Pihlajalinna Plc Interim Report 3 May 2024 at 8:00
Pihlajalinna Interim Report 1 January-31 March 2024
Profitability continued to improve, operating... ► Artikel lesen | |
03.05.24 | Pihlajalinna Oyj: Pihlajalinna Interim Report 1 January-31 March 2024: Profitability continued to improve, operating cash flow was strong | 73 | GlobeNewswire (Europe) | Pihlajalinna Plc Interim Report 3 May 2024 at 8:00
Pihlajalinna Interim Report 1 January-31 March 2024
Profitability continued to improve, operating... ► Artikel lesen | |
30.04.24 | Pihlajalinna Oyj: Insider information, profit warning: Pihlajalinna decreases its revenue outlook as the cost liability of demanding care transfers to the well-being services county of South Ostrobothnia | 76 | GlobeNewswire (Europe) | Pihlajalinna Plc Insider Information 30 April 2024 at 2:30 p.m.
Insider information, profit warning: Pihlajalinna decreases its revenue outlook as the cost liability of demanding care transfers... ► Artikel lesen | |
11.04.24 | Dividendenbekanntmachungen (11.04.2024) | 15.841 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADVANCE AUTO PARTS INC US00751Y1064 0,25 USD 0,2327 EUR ALMACENES EXITO SA ADR US02028M1053 0,012 USD 0,0112 EUR AMERICAN EAGLE... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BICO GROUP | 2,944 | -1,80 % | DKSH schliesst strategische Partnerschaft mit Cellink in China | Zürich - DKSH hat eine strategische Partnerschaft mit Cellink für Bioprinting-Lösungen in China geschlossen. Das auf Expansionsdienstleistungen spezialisierte Unternehmen werde Cellink durch sein umfangreiches... ► Artikel lesen | |
PING AN HEALTHCARE | 0,808 | -4,24 % | Ping An Healthcare and Technology Company Limited: Ping An Health Reports First Full-Year Profit in 2024 | Synergies Between Health Care and Insurance Drive Scalable GrowthAI Innovations Fuel Continued Success
SHANGHAI and HONG KONG, March 13, 2025 /PRNewswire/ -- Ping An Healthcare and Technology... ► Artikel lesen | |
EMEIS | 11,008 | +0,82 % | New Partnership Between NLV and emeis for Affordable Care Facilities in the Netherlands | Regulatory News:
emeis (Paris:EMEIS) and the real estate asset manager NLV have signed a partnership, to support the expansion of emeis Group in the Netherlands, and marking NLV's first investment... ► Artikel lesen | |
CYTOSORBENTS | 0,960 | +3,34 % | Cytosorbents FY Earnings Preview | ||
CLARIANE | 4,296 | -1,92 % | Clariane: Governance Evolution - Mrs Sylvia Metayer, Independent Director, Appointed Chairwoman of the Board of Directors With Effect From May 14th, 2025 | Mrs Sylvia Metayer will succeed Mr Jean-Pierre Duprieu as Chair of the Clariane Board of Directors at the close of the 2025 General Meeting. At the same General Meeting, Mr Olivier Bogillot... ► Artikel lesen | |
ARJO | 3,428 | -0,06 % | Arjo AB Aktie: Umsatzplus im überblickbaren Bereich! | Der schwedische Medizintechnikkonzern meldet Umsatzsteigerung trotz volatiler Börsenperformance und erhält wichtige FDA-Zulassung für neue Diagnostiktechnologie. Arjo AB hat für Dienstag, den 29. April... ► Artikel lesen | |
M3 INC | 10,400 | -0,95 % | Investoren meiden heute das Wertpapier von M3: Kurs gibt deutlich nach (10,25 €) | Die Aktie von M3 zählt am Dienstag zu den großen Verlierern am Aktienmarkt. Der Kurs des Anteilsscheins sackt kräftig ab. Kein guter Tag bislang für Inhaber von M3: Das Wertpapier weist zur Stunde einen... ► Artikel lesen | |
INTERPACE BIOSCIENCES | 0,860 | 0,00 % | Interpace Biosciences, Inc.: Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2024 Financial and Business Results | Q4 and FY Test volume increase 21% and 17% year-over-year -Q4 and FY Volume, Revenue, and Profitability at all-time record levels PARSIPPANY, NJ, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Interpace Biosciences... ► Artikel lesen | |
NYXOAH | 6,480 | -7,69 % | Nyxoah: FDA signalisiert mögliche Zulassung für Genio-System | Nyxoah hat von der US-Arzneimittelbehörde FDA einen "Approvable Letter" für das Genio-System erhalten. Die Mitteilung bescheinigt nach Angaben des belgischen Unternehmens vom Mittwoch, dass Nyxoahs... ► Artikel lesen | |
DYNAVOX GROUP | 5,940 | +2,77 % | Notice to Annual General Meeting of Dynavox Group AB | ||
VIVANI MEDICAL | 0,955 | 0,00 % | Vivani Medical, Inc.: Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results | Successful initial administration and full enrollment in first-in-human LIBERATE-1 study of NPM-115 (exenatide implant) in obese and overweight subjects with top-line data expected in mid-2025 Positive... ► Artikel lesen | |
CHINA MEDICAL SYSTEM | 0,875 | -5,41 % | China Medical System Holdings Ltd. (00867) Released its 2024 Annual Results: Focusing on Innovation and Specialty Breakthroughs to Reshape Growth Momentum | SHENZHEN, CHINA, March 21, 2025 (GLOBE NEWSWIRE) -- On March 17, China Medical System Holdings Limited ("CMS" or the "Company") released its 2024 annual results. The Company recorded a turnover of... ► Artikel lesen | |
NANOSONICS | 2,620 | -1,50 % | NANOSONICS LIMITED: Notification of cessation of securities - NAN | ||
MICROPORT SCIENTIFIC | 1,010 | +5,21 % | MICROPORT (00853): ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2024 | ||
NIAGEN BIOSCIENCE | 6,200 | -0,80 % | ChromaDex Aktie: Zuversichtliche Aussichten! | Der ehemalige ChromaDex-Konzern präsentiert sich mit neuem Namen, starken Finanzkennzahlen und Wachstumsaussichten im NAD+-Forschungsbereich für 2025. ChromaDex Corporation, die jetzt unter dem Namen... ► Artikel lesen |